Cargando…

Multiparametric Dual-Time-Point [(18)F]FDG PET/MRI for Lymph Node Staging in Patients with Untreated FIGO I/II Cervical Carcinoma

[(18)F]FDG PET/MRI was shown to have limited sensitivity for N-staging in FIGO I/II cervical carcinoma. Therefore, this prospective study aimed to investigate the additional value of multiparametric dual-time-point PET/MRI and to assess potential influencing factors for lymph node metastasis (LNM) d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weissinger, Matthias, Kommoss, Stefan, Jacoby, Johann, Ursprung, Stephan, Seith, Ferdinand, Hoffmann, Sascha, Nikolaou, Konstantin, Brucker, Sara Yvonne, La Fougère, Christian, Dittmann, Helmut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456388/ https://www.ncbi.nlm.nih.gov/pubmed/36078873 http://dx.doi.org/10.3390/jcm11174943

Ejemplares similares

Diagnostic Performance of Dynamic Whole-Body Patlak [(18)F]FDG-PET/CT in Patients with Indeterminate Lung Lesions and Lymph Nodes
por: Weissinger, Matthias, et al.
Publicado: (2023)

Non-invasive estimation of split renal function from routine (68)Ga-SSR-PET/CT scans
por: Weissinger, Matthias, et al.
Publicado: (2023)

Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI Study
por: Reinert, Christian Philipp, et al.
Publicado: (2023)

Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient
por: Vogel, Jonas, et al.
Publicado: (2023)

How [18F]-FDG-PET/CT Affects Clinical Management of Patients with Germ Cell Tumors in the Real World
por: Liang, Cecilia, et al.
Publicado: (2023)

Independent attenuation correction of whole body [(18)F]FDG-PET using a deep learning approach with Generative Adversarial Networks
por: Armanious, Karim, et al.
Publicado: (2020)

Development of a Hybrid-Imaging-Based Prognostic Index for Metastasized-Melanoma Patients in Whole-Body 18F-FDG PET/CT and PET/MRI Data
por: Küstner, Thomas, et al.
Publicado: (2022)

Clinical and prognostic value of tumor volumetric parameters in melanoma patients undergoing (18)F-FDG-PET/CT: a comparison with serologic markers of tumor burden and inflammation
por: Reinert, Christian Philipp, et al.
Publicado: (2020)

[18F]Fluoride Positron-Emission Tomography (PET) and [18F]FDG PET for Assessment of Osteomyelitis of the Jaw in Comparison to Computed Tomography (CT) and Magnetic Resonance Imaging (MRI): A Prospective PET/CT and PET/MRI Pilot Study
por: Reinert, Christian Philipp, et al.
Publicado: (2022)

Computed diffusion weighted imaging (cDWI) and voxelwise-computed diffusion weighted imaging (vcDWI) for oncologic liver imaging: A pilot study
por: Seith, Ferdinand, et al.
Publicado: (2018)

FDG uptake heterogeneity in FIGO IIb cervical carcinoma does not predict pelvic lymph node involvement
por: Brooks, Frank J, et al.
Publicado: (2013)

Correlation of C-arm CT acquired parenchymal blood volume (PBV) with (99m)Tc-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up
por: Weissinger, Matthias, et al.
Publicado: (2020)

Is there a link between very early changes of primary and secondary lymphoid organs in (18)F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?
por: Seith, Ferdinand, et al.
Publicado: (2020)

Influence of 99m-Tc-Nanocolloid Activity Concentration on Sentinel Lymph Node Detection in Endometrial Cancer: A Quantitative SPECT/CT Study
por: Sahbai, Samine, et al.
Publicado: (2020)

SUV-quantification of physiological lung tissue in an integrated PET/MR-system: Impact of lung density and bone tissue
por: Seith, Ferdinand, et al.
Publicado: (2017)

Diagnosing Lung Nodules on Oncologic MR/PET Imaging: Comparison of Fast T1-Weighted Sequences and Influence of Image Acquisition in Inspiration and Expiration Breath-Hold
por: Schwenzer, Nina F., et al.
Publicado: (2016)

Impact of (18)F-FDG-PET/CT on Clinical Management in Patients with Cholangiocellular Carcinoma
por: Kiefer, Lena Sophie, et al.
Publicado: (2021)

A whole-body FDG-PET/CT Dataset with manually annotated Tumor Lesions
por: Gatidis, Sergios, et al.
Publicado: (2022)

Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience
por: Hectors, Stefanie J., et al.
Publicado: (2018)

Long-term prognostic factors for PRRT in neuroendocrine tumors
por: Trautwein, Nils Florian, et al.
Publicado: (2023)

Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
por: Kurucay, Mustafa, et al.
Publicado: (2017)

Tumor Burden and Intraosseous Metabolic Activity as Predictors of Bone Marrow Failure during Radioisotope Therapy in Metastasized Prostate Cancer Patients
por: Fiz, Francesco, et al.
Publicado: (2017)

Diagnostic Value of (18)F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2021)

Influence of [(18)F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients—A PET/CT Registry Study
por: Werner, Sebastian, et al.
Publicado: (2023)

Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy
por: Thaiss, Wolfgang M., et al.
Publicado: (2022)

Risk Factor Assessment of Lymph Node Metastasis in Patients With FIGO Stage IB1 Cervical Cancer
por: Xu, Mu, et al.
Publicado: (2022)

Automated Definition of Skeletal Disease Burden in Metastatic Prostate Carcinoma: A 3D Analysis of SPECT/CT Images
por: Fiz, Francesco, et al.
Publicado: (2019)

Pretreatment [(18)F]FDG PET/CT Prognostic Factors in Patients with Squamous Cell Cervical Carcinoma FIGO IIIC1
por: Burchardt, Ewa, et al.
Publicado: (2021)

The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter
por: Nicolai, Laure, et al.
Publicado: (2023)

FIGO Award for Professor Marleen Temmerman
por: Vergote, I.
Publicado: (2009)

The FIGO Ovulatory Disorders Classification System
por: Munro, Malcolm G, et al.
Publicado: (2022)

The FIGO ovulatory disorders classification system
por: Munro, Malcolm G., et al.
Publicado: (2022)

FIGO staging of endometrial cancer: 2023
por: Berek, Jonathan S., et al.
Publicado: (2023)

A whole-body FDG PET/MR atlas for multiparametric voxel-based analysis
por: Sjöholm, Therese, et al.
Publicado: (2019)

Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification
por: Paik, E Sun, et al.
Publicado: (2015)

Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009
por: Zhang, Yunqiang, et al.
Publicado: (2022)

Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer?
por: Pedone Anchora, Luigi, et al.
Publicado: (2020)

Injury of the Tibial Nutrient Artery Canal during External Fixation for Lower Extremity Fractures: A Computed Tomography Study
por: Almansour, Haidara, et al.
Publicado: (2020)

Hybrid-PET/MRT bei inflammatorischer Kardiomyopathie
por: Krumm, Patrick, et al.
Publicado: (2022)

FIGO staging in ovarian carcinoma and histological subtypes
por: Kehoe, Sean
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_309teekdah0vpjavr7pln5tshd